Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis

doi:10.3748/wjg.v18.i19.2402

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4932)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

435

HTML

4233

Figures (1-1)

132

Tables (1-2)

132

Sum=4932

May 21, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2012; 18(19): 2402-2407
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2402

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curve in patients positive and negative for human epidermal growth factor receptor 2 in the liver metastatic gastric cancer. HER2: Human epidermal growth factor receptor 2.

Citation: Dang HZ, Yu Y, Jiao SC. Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis. World J Gastroenterol 2012; 18(19): 2402-2407
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2402.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2402